Give Prostate Cancer The Boot With Millstone!

We’re delighted to be partnered with Prostate Cancer UK during 2020.

From January 1st 2020, Swift360 will donate 10p to Prostate Cancer UK for every Millstone product sold, whether it’s workwear or safety footwear. The donation will apply regardless of whether the goods are purchased from Swift360 or through other selected resellers.

This will help raise much needed funds and awareness of the disease.

"We want to thank Millstone and Swift360 for choosing to support Prostate Cancer UK and helping us spread an important health message to their customers. The money raised through sales of their products will go towards helping Prostate Cancer UK fund vital research into the disease. Prostate cancer is the most common cancer in men and the third biggest cancer killer overall. With the support of partners such as Millstone and Swift360, we're able to continue with our goal to save men's lives and stop prostate cancer being a killer. For this, we're extremely grateful."
Jon Eserin
Director of Fundraising, Prostate Cancer UK

Who Are Prostate Cancer UK?

  • Prostate Cancer UK's top priority is to fund research to stop prostate cancer killing men. They also spread the word about who is at risk.
  • In the last 20 years, Prostate Cancer UK have invested over £37 million into research and continue to provide award-winning support for men.
  • Prostate Cancer UK provide health information and work with the NHS to ensure men get access to breakthrough tests and treatments.
  • Visit now to help beat this disease!

Prostate Cancer - The Facts

  • Prostate cancer is the most common cancer in men.
  • More than 47,500 men are diagnosed with prostate cancer each year. That's 129 men every day.
  • Over 11,500 men die from prostate cancer in the UK every year. That's one man every 45 minutes!
  • One in eight men will be diagnosed with prostate cancer in their life. The risk is even higher for black men and men with a family history of prostate cancer.
  • Around 400,000 men are living with and after prostate cancer.
Back to top